Goldman Sachs Asks 'Is Curing Patients A Sustainable Business Model?'Turning the search for medical remedies into a numbers game, analyst Salveen Richter called potential "one shot cures" a bad business decision that will hurt a company's bottom line.
Goldman Sachs Firm, Employees Won't Be Prosecuted
Norm Is Serving Fierce Independence On Wall Street
Thom Gets Into Goldman Sachs, Social Security & Prescription Drugs, Today On The Thom Hartmann Show!

Listen Live